Title: Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor.
Journal: Investigational new drugs 20140401
Title: Cellular impedance assays for predictive preclinical drug screening of kinase inhibitor cardiovascular toxicity.
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20131001
Title: Summary of presentation from the targeted therapy in lung cancer meeting.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111101
Title: New insights into checkpoint kinase 1 in the DNA damage response signaling network.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20100115
Title: King C, et al. Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor. Invest New Drugs. 2014 Apr;32(2):213-26.
Title: Wang G, et al. Panobinostat synergistically enhances the cytotoxic effects of cisplatin, doxorubicin or etoposide on high-risk neuroblastoma cells. PLoS One. 2013 Sep 30;8(9):e76662.
